The window after recovering from SARS-CoV-2 infection when people could donate serum that has sufficiently high antibody levels may be limited. Implications for health care personnel with antibodies assigned to care for infected patients depend on whether decline in these antibodies increases risk of reinfection and disease, which remains unknown, especially given the lack of data on memory B-cell and T-cell responses. Limitations of this study include its single-center setting, small sample size, convenience sampling, and lack of information on timing of infection to evaluate antibody kinetics.
No takes yet. Share an insight, caveat, or question.
Ahlberg et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: